Identification of categories at risk for high quality of life impairment in patients with vitiligo.

Identification of categories at risk for high quality of life impairment in patients with vitiligo. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Identification of categories at risk for high quality of life impairment in patients with vitiligo. Abstract Text:

BACKGROUND: Quality of life (QoL) in patients with vitiligo is strongly impaired. Therefore, it seems inadequate to describe the severity of the disease using only physical indicators. OBJECTIVES: To investigate the QoL of patients with vitiligo, identifying categories at risk for high impairment, also analysing single questions from a QoL instrument. METHODS: The Skindex-29 questionnaire, a QoL dermatology-specific instrument, was completed by 181 consecutive patients with vitiligo. Answers to the Skindex-29 items were given on a five-point scale, from 'never' to 'all the time'. Results The QoL problems more frequently experienced 'often' or 'all the time' were: worry of the disease getting worse (60%), anger (37%), embarrassment (34%), depression (31%), having social life affected (28%), and shame (28%). The prevalence of patients with probable depression or anxiety, evaluated using the 12-item General Health Questionnaire, was 39%, and the prevalence of patients with alexithymia, evaluated using the 20-item Toronto Alexithymia Scale, was 24%. The association of QoL impairment with psychological problems was very strong for all the items, and remained significant also when taking into account simultaneously gender, age, clinical severity, family history, and localization of vitiligo. CONCLUSIONS: Detailed information on QoL in patients with vitiligo may lead dermatologists to pay particular attention to patient categories at risk for a high QoL impairment.

Identification of categories at risk for high quality of life impairment in patients with vitiligo. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Identification of categories at risk for high quality of life impairment in patients with vitiligo. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: The British journal of dermatology

VOLUME: 159

Page Numbers: 351-9

Journal Abbreviation: Br. J. Dermatol.

ISSN: 1365-2133

DAY: 28

MONTH: 06

YEAR: 2008

Identification of categories at risk for high quality of life impairment in patients with vitiligo. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 4041

Identification of categories at risk for high quality of life impairment in patients with vitiligo. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Identification of categories at risk for high quality of life impairment in patients with vitiligo. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Identification of categories at risk for high quality of life impairment in patients with vitiligo.

AFFILIATION: Health Services Research Unit, Istituto Dermopatico dell'Immacolata IDI-IRCCS, Cia dei Monti di Creta, Rome, Italy.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Br J Dermatol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Identification of categories at risk for high quality of life impairment in patients with vitiligo Related Publications

• Anti-tumor necrosis factor alpha therapy in psoriatic arthritis and psoriasis.
• Can cognitive-behavioral therapy help patients with vitiligo?
• Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions.
• Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals.
• Identification of categories at risk for high quality of life impairment in patients with vitiligo.
• Measuring the health status of patients with vascular leg ulcers and the burden for their caregivers.
• Performance of the self-administered psoriasis area and severity index in evaluating clinical and sociodemographic subgroups of patients with psoriasis.
• The health impact of pemphigus vulgaris and pemphigus foliaceus assessed using the Medical Outcomes Study 36-item short form health survey questionnaire.
• The impact of changes in clinical severity on psychiatric morbidity in patients with psoriasis: a follow-up study.